Talquetamab plus daratumumab demonstrated durable and deep responses in heavily pre-treated patients with refractory multiple myeloma (MM). Furthermore, the combination regimen was tolerable and did not show overlapping...
Read MoreSGLT2 inhibitors were associated with a significant reduction in atrial arrhythmias (AA) and all-cause mortality in patients with cardiac implantable electronic devices (CIED). The results of this real-world study indicate that...
Read MoreThank you to all our respondents! How did you do compared to your colleagues?
Read MoreScan review accuracy comparable to the that of radiologists CHICAGO—A comparison study in which mammogram reviews by radiologists were compared to reviews of mammograms by an artificial intelligence (AI) algorithm found...
Read MoreAnticoagulants add to risk of delayed brain hemorrhage CHICAGO—A negative imaging study on a head trauma patient doesn’t necessarily put the individual out-of-the-woods for a devastating intracranial...
Read MoreCT technology suggests dino-sized toothache CHICAGO—When ’Tristan Otto’—one of the world’s most complete Tyrannosaurus rex skeletons—died 68 million years ago, it is likely he wasn’t a...
Read MoreCovid vaccine rollout failed to prioritize cancer patients CHICAGO—When Covid-19 vaccinations were rolled out, the early releases by health agencies failed to specify that cancer patients should have been included among...
Read More
New strategies for the promotion of guideline-recommended cholesterol management in young adults...
Read More
A meta-analysis showed that dapagliflozin was associated with increased stroke volumes (SV) in...
Read More
A remote, algorithm-driven program with over 10,000 enrolled participants was able to reduce...
Read MorePatients with gout have significantly greater intercritical inflammation and lumbosacral spine monosodium urate crystal (MSU) deposition when compared with those without the condition, and trend toward greater deposition among...
Read MorePegloticase is effective for lowering serum urate patients with uncontrolled or refractory gout, although more than half of patients experience anti-drug antibody development which limits its efficacy.1 Administering pegloticase...
Read MoreThe American Society of Hematology Annual Meeting & Exposition (ASH 2021) Will be held December 11-14, 2021 at the Georgia World Congress Center in Atlanta, as well as virtually. The “premier event in malignant and...
Read More(WASHINGTON, Nov. 22, 2021) – The American Society of Hematology (ASH) will honor Representative Rosa DeLauro (D-CT) for her outstanding support of hematology research at the 2021 ASH Annual Meeting, December 11-14, in Atlanta,...
Read More(WASHINGTON, Nov. 22, 2021) – The American Society of Hematology (ASH) will honor Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) for his...
Read MoreMIRROR RCT (NCT03994731) phase III data support the combination of immunosuppression with pegloticase treatment for uncontrolled gout in all patients, raising the response rate from 40-42% to 71%. Physician’s Weekly spoke with...
Read More
